Increased blood cobalt and chromium after total hip replacement

Journal of Toxicology - Clinical Toxicology

Volumn 37, Issue 7, 1999, Pages 839-844

  Schaffer, Andreas W ^b   Pilger, Alexander ^c   Engelhardt, Christa ^a   Zweymueller, Karl ^a   Ruediger, Hugo W ^c  

^a Orthopaedic Hospital Gersthof   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; CHROMIUM; COBALT; METAL ION;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; BODY FLUID; CONTROLLED STUDY; FEMALE; HEAVY METAL POISONING; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; TOTAL HIP PROSTHESIS; URINE LEVEL;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; CHROMIUM; COBALT; FEMALE; HUMANS; MALE; POSTOPERATIVE PERIOD; SPECTROPHOTOMETRY, ATOMIC;

EID: 0033372378     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102463     Document Type: Article

References (30)

1. McKee GK, Watson-Farrar J. Replacement of arthritic hips by the McKee-Farrar prosthesis. J Bone Joint Surg 1966;48B:245-259.
2. Ring PA. Complete replacement arthroplasty of the hip by the ring prosthesis. J Bone Joint Surg 1968;50B:720-731.
3. Zweymuller K, Deckner A, Kupferschmidt W, Steindl M. Further development of the conical threaded cup. Med Orthop Technik 1994;114:223-228.
4. Carnley J. The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg 1972;54B:61-76.
5. Courtland GL, Sunderman FW. Metal carcinogenesis in total joint arthroplasty. Clin Orthop 1996;329:S264-S268.
6. Case CP, Langkamer VG, James C, et al. Widespread dissemination of metal debris from implants. J Bone Joint Surg 1994;76B:701-712.
7. Case CP, Langkamer VG, Howell RT, et al. Preliminary observations on possible premalignant changes in hone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop 1996;329:S269-S279.
8. Howie DW, Rogers SD, McGee MA, Haynes DR. Biologic effects of cobalt chrome in cell and animal models. Clin Orthop 1996;329:S217-S232.
9. Amstutz HC, Campbell PA, McKellop H, et al. Metal on metal total hip replacement workshop consensus document. Clin Orthop 1996;329:S297-S303.
10. Chromium. In: Environmental Health Criteria 61, World Health Organization, 1988.
11. Friberg L, Nordberg GF, Vouk VB. Handbook on the Toxicology of Metals. Holland: Elsevier 1979:235-255.
12. Svartengren M, Elinder CG. Cobalt and its compounds. In: Occupational Medicine, 3rd Edition. Zenz C, Dickerson BO, Horvath EP, eds., St. Louis, Missouri: Mosby-Year Book 1994:453-457.
13. Jacobs JJ, Skipor AK, Doom PF, et al. Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop 1996;329:S256-S263.
14. Merritt K, Crowe TD, Brown SA. Elimination of nickel. cobalt and chromium following repeated injections of high dose metal salts. J Biomed Mater Res 1989;23:845-862.
15. Deutsche Forschungsgemeinschaft. Expositionäquivalente für Krebserzeugende Arbeitsstoffe. Germany: VCH-Verlag Weinheim 1992.
16. Angerer J, Schaller KH. Analyses of Hazardous Substances in Biological Materials. Germany: VCH-Verlag Weinheim 1991:46-59.
17. Coleman RF, Herrington J, Scales JT. Concentration of wear products in hair, blood and urine after total hip replacement. BMJ 1973;1:527-529.
18. Täger KH. Aspects of loosening in McKee-Farrar endoprothesis. In: Technical Principles, Design and Safety of Joint Implants. Buchhorn GI, Willert HG, eds., Seattle: Hogrefe & Huber 1994:72-81.
19. Schumacher-Wittkopf E. Characterisation of cobalt binding proteins in occupational cobalt exposure. Taxicol Environ Chem 1984;8:1-9.
20. Hennig FF, Raithel HJ, Schaller KH, Döhler JR. Nickel-, chrom-, and cobalt-concentrations in human tissue and body fluids of hip prosthesis patients. J Trace Elem Electrolytes Health Dis 1992;6:239-243.
21. Linnainmaa M, Kiilunen M. Urinary cobalt as a measure of exposure in the wet sharpening of hard metal and stellite blades. Int Arch Occup Environ Health 1997;69:193-200.
22. Ichikawa Y, Kusaka Y, Goto S. Biological monitoring of cobalt exposure, based on cobalt concentrations in blood and urine. Int Arch Occup Environ Health ;55:269-276.
23. Merritt K, Brown SA, Sharkey NA. The binding of metal salts and corrosion products to cells and proteins in vitro. J Biomed Mater Res 1984;18:1005-1015.
24. Bartolozzi A, Black J. Chromium concentrations in serum, blood clot and urine from patients following total hip arthroplasty. Biomaterials 1985;6:2-8.
25. Merritt K, Wenz LM, Brown SA. Cell association of fretting corrosion products generated in a cell culture. J Orthop Res 1991;9:289-296.
26. Brown SA, Farnsworth LJ, Merrit K, Crowe TD. In vitro and in vivo metal ion release. J Biomed Mater Res 1988; 22:321-338.
27. Lewalter J, Korallus U, Harzdorf C, Weidemann H. Chromium bond detection in isolated erythrocytes; A new principle of biological monitoring of exposure to hexavalent chromium. Int Arch Occup Environ Health 1985;55: 305-318.
28. Michel R, Nolte M, Reich M, Loer F. Systemic effects of implanted prosthesis made of cobalt-chromium alloys. Arch Orthop Trauma Surg 1991;110:61-74.
29. Gray SJ, Stiring K. The tagging of red blood cells and plasma proteins with radioactive chromium. J Clin Invest 1950;29:1604-1610.
30. Jarvis JQ, Hammond E, Meier R, Robinson C. Cobalt cardiomyopathy. J Occup Med 1992;34:620-626.